SubHero Banner
Text

Venclexta® (venetoclax) – Expanded indication

May 16, 2019 - Roche announced the FDA approval of Venclexta (venetoclax), for the treatment of adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).

Download PDF